Summaries by Inventor Weihl, Conrad
Weihl, Conrad
T-019285
— Transgenic mouse strain designed and developed by Dr. Conrad Weihl with a mutation of the DNAJB6 gene at the F90I protein. This homologous with the human form of muscular dystrophy with patients having a genetic variant at the F89I protein.
human iPSC cells to model VCPWeihl, Conrad
T-019162
— Valosin Containing Protein (VCP) patient derived fibroblasts, reprogrammed into iPSC cells and corresponding gene corrected line. These cells can be used to model VCP associated muscle disease, ALS, and dementia.
Gene-Specific Therapy Treatment for Predicting Limb-Girdle Muscular DystrophyHaller, Gabriel ; Li, Chengcheng ; Weihl, Conrad
T-020804
— Published Date: 5/14/2025 Value Proposition: Method that uses gene-therapy to detect limb-girdle muscular dystrophy (LGMD) type 4R/2E. Technology Description Researchers at Washington University in St. Louis have developed a method of predicting limb-girdle muscular dystrophy (LGMD) type 4R/2…